Xeris Biopharma Holdings, Inc.
XERS
12 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 1 9:50 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $6.23 | $103.8K | 1,193,173(D) | View → |
| Apr 1, 2026 | Apr 3 9:45 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $5.99 | $99.9K | 1,209,840(D) | View → |
| Mar 30, 2026 | Apr 1 9:54 PM | James Aloysius BradyDirector | Sale | 10,834 | $5.54 | $60.0K | 89,166(D) | View → |
| Mar 30, 2026 | Mar 30 9:31 PM | JAMES BRADY | Proposed Sale | 10,834 | $5.40 | $58.5K | — | View → |
| Mar 2, 2026 | Mar 4 10:28 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $6.25 | $104.1K | 1,226,507(D) | View → |
| Mar 2, 2026 | Mar 2 9:36 PM | BETH HECHT | Proposed Sale | 66,668 | $6.12 | $408.0K | — | View → |
| Feb 2, 2026 | Feb 2 11:11 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $7.45 | $124.1K | 1,243,174(D) | View → |
| Jan 8, 2026 | Jan 8 9:22 PM | KEVIN MCCULLOCH | Proposed Sale | 60,000 | $7.21 | $432.6K | — | View → |
| Dec 19, 2025 | Dec 19 11:15 PM | JOHN H JOHNSON | Proposed Sale | 135,402 | $7.22 | $977.0K | — | View → |
| Dec 12, 2025 | Dec 12 9:20 PM | BARBARA-JEAN A BORMANN-KENNEDY | Proposed Sale | 15,000 | $7.01 | $105.2K | — | View → |
| Nov 13, 2025 | Nov 13 9:25 PM | JOHN SHANNON | Proposed Sale | 48,149 | $7.59 | $365.5K | — | View → |
| Nov 11, 2025 | Nov 12 12:02 PM | BETH HECHT | Proposed Sale | 66,668 | $7.72 | $514.7K | — | View → |
| Sep 11, 2025 | Sep 11 8:24 PM | MARLA PERSKY | Proposed Sale | 15,500 | $7.81 | $121.1K | — | View → |
| Aug 28, 2025 | Aug 28 8:09 PM | JEFFREY SHERMAN | Proposed Sale | 42,232 | $7.92 | $334.5K | — | View → |
| Aug 13, 2025 | Aug 13 8:08 PM | JOHN H JOHNSON | Proposed Sale | 107,500 | $7.32 | $786.5K | — | View → |
| Aug 12, 2025 | Aug 12 8:23 PM | DAWN HALKUFF | Proposed Sale | 42,500 | $7.28 | $309.2K | — | View → |
| May 9, 2025 | May 9 9:28 PM | Fairley Ricki Louise | Proposed Sale | 56,667 | $4.90 | $277.7K | — | View → |
| Mar 20, 2025 | Mar 20 9:26 PM | Hecht Beth | Proposed Sale | 40,000 | $5.14 | $205.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 16 10:11 PM | Kevin MccullochPresident and Chief Operating Officer | Option Exercise | 48,898 | $4.09 | 79,996(D) | View → |
| Mar 5, 2026 | Mar 6 12:18 AM | Steven PieperChief Financial Officer | Option Exercise | 41,927 | $5.93 | 0(D) | View → |
| Jan 30, 2026 | Feb 2 11:13 PM | John Patrick Shannon JrDirector, Chief Executive Officer and Director | Grant/Award | 639,639 | $7.36 | 639,639(D) | View → |
| Jan 30, 2026 | Feb 2 11:12 PM | Kevin MccullochPresident and Chief Operating Officer | Grant/Award | 225,225 | $7.36 | 225,225(D) | View → |
| Jan 30, 2026 | Feb 2 11:12 PM | Steven PieperChief Financial Officer | Grant/Award | 207,207 | $7.36 | 207,207(D) | View → |
| Jan 30, 2026 | Feb 2 11:11 PM | Anh Tu NguyenChief Medical Officer | Grant/Award | 162,162 | $7.36 | 162,162(D) | View → |
| Jan 30, 2026 | Feb 2 11:11 PM | Beth HechtChief Legal Officer and Corporate Secretary | Grant/Award | 162,162 | $7.36 | 162,162(D) | View → |